Clinical Trial Update: Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial from the University of Oxford studying the B cell response to pneumococcal vaccines in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: University of Oxford | Conditions: Pneumococcal Disease | Phase 3 | Status: COMPLETED